Bortezomib in Treating Young Patients With Refractory or Recurrent Leukemia

Clinical trial NCT00077467 · COMPLETED

Trial details

NCT number: NCT00077467
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Blastic Phase Chronic Myelogenous Leukemia Childhood Acute Promyelocytic Leukemia (M3)Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia

Start date: 2004-01-01
Primary completion: 2006-03-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.